Literature DB >> 19876903

Cytogenetic and molecular characterization of a partial trisomy 2p arising from inverted duplication of 2p with terminal deletion of 2pter.

Carlos A Tirado1, Samuel Henderson, Naseem Uddin, Ewa Stewart, Santha Iyer, Ian M Ratner, Erin Matthews, Jeffrey Doolittle, Rolando Garcia, Federico Valdez, Stephanie Dallaire, Taylor Appleberry, Deborah Payne, Robert Collins.   

Abstract

Partial trisomy 2p is typically associated with partial monosomy of another chromosomal segment and results from a balanced translocation in one of the parents. Inverted duplications with terminal deletions have been reported in an increasing number of chromosomes. Several cases initially interpreted as terminal duplications have instead been documented to represent inverted duplications with terminal deletions. Inv dup del(2p) has been reported in patients who manifest the clinical findings of trisomy 2p syndrome. Here we report on a 2-month-old girl with inv dup del(2p) and clinical manifestations that overlap those found commonly in partial 2p trisomy, as previously reported in the literature. Her clinical picture helps delineate the phenotype of 2p duplication disorders. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19876903     DOI: 10.1002/ajmg.a.33080

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  A Two-Month-Old Child with Vascular Ectasia: A Case Report Diagnosed by Molecular Karyotyping.

Authors:  Ozlem Tolu Kendir; Hayri Levent Yilmaz; Sevcan Bozdogan; Atıl Bisgin; Tugçe Celik; Ozgur Surmelioglu; Figen Doran
Journal:  J Pediatr Genet       Date:  2018-08-22

2.  Sox11 is required to maintain proper levels of Hedgehog signaling during vertebrate ocular morphogenesis.

Authors:  Lakshmi Pillai-Kastoori; Wen Wen; Stephen G Wilson; Erin Strachan; Adriana Lo-Castro; Marco Fichera; Sebastiano A Musumeci; Ordan J Lehmann; Ann C Morris
Journal:  PLoS Genet       Date:  2014-07-10       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.